Open0.270 | Close0.262 |
Vol / Avg.96.508K / 215.510K | Mkt Cap2.995M |
Day Range0.255 - 0.279 | 52 Wk Range0.210 - 4.190 |
Yield10 Bioscience Stock (NASDAQ: YTEN) stock price, news, charts, stock research, profile.
Open0.270 | Close0.262 |
Vol / Avg.96.508K / 215.510K | Mkt Cap2.995M |
Day Range0.255 - 0.279 | 52 Wk Range0.210 - 4.190 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.410 | -0.0200 | ||||
REV | 70.000K | 0 | -70.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.540 | -0.640 | -0.1000 | ||||
REV | 30.000K | 0 | -30.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-16 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2023-11-16 | HC Wainwright & Co. | Amit Dayal | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-17 | HC Wainwright & Co. | Amit Dayal | Maintains | BuyBuy | Lowers | 25.00 | 4.00 |
2023-08-16 | Lake Street | Ben Klieve | Maintains | BuyBuy | Lowers | 12.00 | 3.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
YTEN | Yield10 Bioscience | -7.3% | 3M |
PBLA | Panbela Therapeutics | -3.68% | 2.6M |
DRMA | Dermata Therapeutics | 0.01% | 2.4M |
THAR | Tharimmune | -2.89% | 1.8M |
CYCC | Cyclacel Pharmaceuticals | -7.74% | 3.4M |
You can purchase shares of Yield10 Bioscience (NASDAQ: YTEN) through any online brokerage.
Other companies in Yield10 Bioscience’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by Maxim Group on Thursday, November 16, 2023. The analyst firm set a price target for 0.00 expecting YTEN to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Yield10 Bioscience (NASDAQ: YTEN) is $0.25 last updated December 5, 2023 at 10:44 PM UTC.
There is no dividend information for Yield10 Bioscience.
Yield10 Bioscience’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Yield10 Bioscience.
Yield10 Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.